SURG.00161 Nanoparticle-Mediated Thermal Ablation

This policy addresses nanoparticle-mediated thermal ablation for cancer treatment, including therapies like NanoTherm that use iron oxide nanoparticles activated by external energy (e.g., alternating magnetic fields) to induce hyperthermia. Anthem deems this technology investigational/experimental and not medically necessary; therefore, it is not covered. Coverage is excluded for all indications with no exceptions or circumstances under which it is considered medically necessary.

"Nanoparticle-mediated thermal ablation is consideredinvestigational and not medically necessaryfor all indications."

Sign up to see full coverage criteria, indications, and limitations.